Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: new insight into CXCR4-FC131 interactions.

Bioorg Med Chem Lett

Drug Discovery Department, Research & Development Division, PharmaDesign, Inc., Tokyo, Japan.

Published: March 2012

CXCR4 is a G-protein coupled receptor that is associated with many diseases such as breast cancer metastasis, HIV infection, leukemic disease and rheumatoid arthritis, and is thus considered an attractive drug target. Previously, we identified a cyclic pentapeptide, FC131, that is a potent antagonist for CXCR4. In this study, we constructed a three dimensional model of the CXCR4-FC131 complex. To investigate the backbone flexibility of FC131, we performed molecular dynamics simulations of FC131 based on the NMR structure of FC131, and obtained snapshot structures from the trajectories which were used to model the docking pose of FC131 into CXCR4. Our final model of the CXCR4-FC131 complex is partially different from the X-ray crystal structure of CXCR4-CVX15 and suggests water-mediated interactions. Nevertheless, this docking pose is consistent with the experimental data. We believe our model will aid in the discovery and development of small-molecule antagonists for CXCR4.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2012.01.134DOI Listing

Publication Analysis

Top Keywords

cyclic pentapeptide
8
model cxcr4-fc131
8
cxcr4-fc131 complex
8
docking pose
8
cxcr4
5
fc131
5
molecular modeling
4
modeling study
4
study cyclic
4
pentapeptide cxcr4
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!